Evotec SE (EVOTF) EBITDA Margin (2020 - 2025)
Evotec SE's (EVOTF) quarterly EBITDA Margin came in at 22.9% in Q4 2025, up 1001.0% year-on-year from 2.08% in Q4 2024, and up 184.33% quarter-over-quarter from 27.15% in Q3 2025.
Evotec SE (EVOTF) EBITDA Margin (2020 - 2025) Analysis & Trends
Evotec SE has disclosed EBITDA Margin across 6 years of filings, most recently posting 22.9% for Q4 2025.
- EBITDA Margin for Q4 2025 came in at 22.9%, up 1001.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 1.82% (down 356.0% YoY), and the FY2025 annual result was 0.01%, down 283563.0% from the prior year.
- EBITDA Margin came in at 22.9% for Q4 2025 at Evotec SE, up from 27.15% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 22.9% in Q4 2025 to a low of 27.15% in Q3 2025.
- The 5-year median for EBITDA Margin is 8.66% (2023), against an average of 3.86%.
- Across the five-year window, EBITDA Margin plunged 2126860 bps in 2021 and surged 1001 bps in 2025, its largest moves.
- Evotec SE's EBITDA Margin stood at 16.26% in 2021, then tumbled by 46 bps to 8.73% in 2022, then retreated by 1 bps to 8.66% in 2023, then soared by 49 bps to 12.88% in 2024, then soared by 78 bps to 22.9% in 2025.
- The last three EBITDA Margin figures came in at 22.9% (Q4 2025), 27.15% (Q3 2025), and 12.88% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Evotec SE | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.90% |
| Sep 30, 2025 | -27.15% |
| Dec 31, 2024 | 12.88% |
| Sep 30, 2024 | -14.33% |
| Dec 31, 2023 | 8.66% |
| Sep 30, 2023 | 6.21% |
| Jun 30, 2023 | -21.31% |
| Dec 31, 2022 | 8.73% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | -2.19% |
| Mar 31, 2022 | 11.45% |
| Dec 31, 2021 | 16.26% |
| Sep 30, 2021 | 11.11% |
| Jun 30, 2021 | 1.11% |
| Mar 31, 2021 | 15.86% |
| Dec 31, 2020 | 21,284.87% |